Results 231 to 240 of about 86,485 (257)

Incidence of Hepatitis B Virus Reactivation in Patients Treated With Immunosuppressive and Chemotherapeutic Agents

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 5, Page 625-634, September 2026.
HBV reactivation incidence varied across immunosuppressive and chemotherapeutic agents. Clinically meaningful HBV reactivation was also observed in patients receiving corticosteroids and conventional immunosuppressive therapies. ABSTRACT Background Data on the incidence of hepatitis B virus reactivation (HBVr) remain limited. In Japan, patients who are
Kazuhiko Ikeuchi, Makoto Saito, Kazuya Okushin, Toshiyuki Kishida, Akira Kado, Kyoji Moriya, Kazuhiko Koike, Takeya Tsutsumi, Hiroshi Yotsuyanagi   +8 more
wiley   +1 more source

Effects of tocilizumab on neutrophil gelatinase-associated lipocalin following out-of-hospital cardiac arrest, and its prognostic value. [PDF]

Resusc Plus
Alaoui-Ismaili Z, Grand J, Frydland M, Obling LER, Wiberg S, Alaoui-Ismaili Y, Møller JE, Frikke-Schmidt R, Kjaergaard J, Hassager C, Meyer MAS.   +10 more
europepmc   +1 more source

Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report. [PDF]

Front Immunol
Liu H, Li Q, Ouyang X, Chen S, Liang H, Ye Y, Cao H, Xue Y, Dai L.   +8 more
europepmc   +1 more source

Primary Sjögren's syndrome-associated interstitial lung disease: a case report with favourable response to tocilizumab. [PDF]

Drugs Context
Naseri N, Jalili N, Rafiei F, Sadeghipour S, Soltani H.   +4 more
europepmc   +1 more source

Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting. [PDF]

Front Immunol
Zhao M, Yu X.
europepmc   +1 more source

A curious case of generalized pruritus in giant cell arteritis. [PDF]

JAAD Case Rep
Dickson T, Enwereji N, Moossavi M.
europepmc   +1 more source

Tocilizumab in FIRES: From Treatment Timing to Treat-to-Target Use [Letter]. [PDF]

J Inflamm Res
Zhang Y, Cao H, Ma X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effective treatment of severe COVID-19 patients with tocilizumab

Proceedings of the National Academy of Sciences of the United States of America, 2020
Mingfeng Han, Haiming Wei, Yang Yun
exaly  

Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

Clinical Microbiology and Infection, 2021
Ja Pérez-Molina, Santiago Moreno, Alfonso Muriel   +2 more
exaly